Ticker Details
Tevogen Bio Holdings Inc. Common Stock
IPO Date:	February 15, 2024
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$43.95M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.17 | 6.67%
Avg Daily Range (30 D):	$0.27 | 4.99%
Avg Daily Range (90 D):	$0.52 | 6.95%

Institutional Daily Volume
Avg Daily Volume:	2.32M
Avg Daily Volume (30 D):	.01M
Avg Daily Volume (90 D):	.02M

Trade Size
Avg Trade Size (Sh.):	367
Avg Trade Size (Sh.) (30 D):	83
Avg Trade Size (Sh.) (90 D):	84

Institutional Trades
Total Institutional Trades:	4
Avg Institutional Trade:	$.83M
Avg Institutional Trade (30 D):	$.98M
Avg Institutional Trade (90 D):	$.98M
Avg Institutional Trade Volume:	.01M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$.86M
Avg Closing Trade (30 D):	$.98M
Avg Closing Trade (90 D):	$.98M
Avg Closing Volume:	18.27K

News

Jul 14, 2026 @ 2:15 AM Tevogen Bio Announces 2026 Annual Meeting of Stock... Source: Na

May 21, 2026 @ 4:15 PM Tevogen Signs Letter of Intent to Evaluate Potenti... Source: Na

Mar 13, 2026 @ 6:45 PM Tevogen Reaffirms Capital Discipline as Lead Inves... Source: Na

Mar 11, 2026 @ 7:15 PM Tevogen CEO Dr. Ryan Saadi Reaffirms Clinical Comm... Source: Na

Mar 6, 2026 @ 5:42 PM Tevogen Bio Explores Buyout To Boost Generics Plat... Source: Vandana Singh

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-1.52	$-1.61	$-7.96
Diluted EPS	$-1.52	$-1.61	$-7.96
Revenue	$-.1M	$-.07M	$-.07M
Gross Profit
Net Income / Loss	$-5.76M	$-5.45M	$-4.68M
Operating Income / Loss	$-5.66M	$-5.4M	$-4.61M
Cost of Revenue
Net Cash Flow	$M	$M	$M
PE Ratio

Splits
Mar 06, 2026	1:50